Related Experiment Video
Updated: Nov 16, 2025

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Apolipoprotein M Gene Polymorphism Rs805297 (C-1065A): Association With Type 2 Diabetes Mellitus and Related
Manal Mohammed Tageldeen1, Hosny Badrawy2, Mona Abdelmeguid3
1Clinical Pathology, Assiut General Hospital, Assiut, Egypt.
Background:
Apolipoprotein M (ApoM) may have a role in the susceptibility of type 2 diabetes mellitus (T2DM). Polymorphisms in the promoter region of the ApoM gene were found to be significantly associated with diabetes. The aim of this study was to investigate the association of ApoM SNP rs805297 (C-1065A) with the susceptibility of T2DM and related microvascular complications in South Egypt.
Methods:
We conducted a case-control study of 60 T2DM patients and 60 healthy control subjects. Lipid profile, fasting, and 2 hours postprandial glucose and creatinine levels were estimated. Patients were subjected to general and Fundus examinations, and screening for nephropathy by urinary albumin levels. ApoM level was assayed by ELISA. Genotyping of the human ApoM gene polymorphism SNP rs805297 (C-1065A) was done by PCR-restriction fragment length polymorphism followed by sequencing to confirm the polymorphism results.
Results:
ApoM was not different between T2DM and the control group (p=0.075) and was negatively correlated with LDL-c (p=0.029). There were significant differences in ApoM genotypes (p=0.001) and allele frequencies (p=0.019) between T2DM and the control group. A significant reduction in FBG, 2hPPG, and HbA1c levels in the heterozygous than the wild genotype in the group with diabetes with no difference in other lab parameters and microvascular complications. The C-allele is associated with lower blood glucose levels and retinopathy. The wild (CC) genotype is considered as a risk factor for developing T2DM in South Egyptians but not CA+AA genotypes.
Conclusions:
In South Egyptians the ApoM polymorphism rs805297 (C-1065A) wild type (CC) was associated with T2DM susceptibility and may have a role in controlling hyperglycemia in these patients. The A-allele is associated with hyperglycemia and diabetic retinopathy.
Insights
The wild (CC) genotype of Apolipoprotein M (ApoM) polymorphism rs805297 is linked to type 2 diabetes mellitus (T2DM) susceptibility in South Egyptians. The A-allele, however, correlates with hyperglycemia and diabetic retinopathy.
Area of Science:
- Genetics
- Endocrinology
- Ophthalmology
Background:
- Apolipoprotein M (ApoM) is implicated in type 2 diabetes mellitus (T2DM) susceptibility.
- Gene promoter polymorphisms in ApoM have shown significant associations with diabetes.
- Investigating specific ApoM gene variations can elucidate T2DM pathogenesis.
Purpose of the Study:
- To examine the association between ApoM single nucleotide polymorphism (SNP) rs805297 (C-1065A) and T2DM risk.
- To evaluate the link between this ApoM polymorphism and T2DM-related microvascular complications.
- To assess the role of ApoM SNP rs805297 in glycemic control within a South Egyptian population.
Main Methods:
- A case-control study involving 60 T2DM patients and 60 healthy controls.
- Measurement of lipid profiles, glucose levels (fasting and postprandial), and creatinine.
- Genotyping of ApoM SNP rs805297 using PCR-RFLP and sequencing, alongside ApoM level assays via ELISA.
Main Results:
- Significant differences in ApoM genotypes (p=0.001) and allele frequencies (p=0.019) were observed between T2DM patients and controls.
- The wild-type (CC) genotype was identified as a risk factor for T2DM in South Egyptians.
- The C-allele was associated with lower blood glucose levels and reduced risk of retinopathy, while the A-allele correlated with hyperglycemia and retinopathy.
Conclusions:
- The ApoM polymorphism rs805297 (C-1065A) wild type (CC) is associated with T2DM susceptibility in South Egyptians.
- This polymorphism may play a role in managing hyperglycemia in T2DM patients.
- The A-allele of ApoM SNP rs805297 is linked to hyperglycemia and diabetic retinopathy in this population.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Coronary Artery Disease I: Introduction

